Comparison of the real-world effectiveness of vertical versus lateral functional hemispherotomy techniques for pediatric drug-resistant epilepsy: A post hoc analysis of the HOPS study.
hemispherectomy
hemispherotomy
seizure outcomes
technique
Journal
Epilepsia
ISSN: 1528-1167
Titre abrégé: Epilepsia
Pays: United States
ID NLM: 2983306R
Informations de publication
Date de publication:
11 2021
11 2021
Historique:
revised:
24
06
2021
received:
26
03
2021
accepted:
15
07
2021
pubmed:
13
9
2021
medline:
19
4
2022
entrez:
12
9
2021
Statut:
ppublish
Résumé
This study was undertaken to determine whether the vertical parasagittal approach or the lateral peri-insular/peri-Sylvian approach to hemispheric surgery is the superior technique in achieving long-term seizure freedom. We conducted a post hoc subgroup analysis of the HOPS (Hemispheric Surgery Outcome Prediction Scale) study, an international, multicenter, retrospective cohort study that identified predictors of seizure freedom through logistic regression modeling. Only patients undergoing vertical parasagittal, lateral peri-insular/peri-Sylvian, or lateral trans-Sylvian hemispherotomy were included in this post hoc analysis. Differences in seizure freedom rates were assessed using a time-to-event method and calculated using the Kaplan-Meier survival method. Data for 672 participants across 23 centers were collected on the specific hemispherotomy approach. Of these, 72 (10.7%) underwent vertical parasagittal hemispherotomy and 600 (89.3%) underwent lateral peri-insular/peri-Sylvian or trans-Sylvian hemispherotomy. Seizure freedom was obtained in 62.4% (95% confidence interval [CI] = 53.5%-70.2%) of the entire cohort at 10-year follow-up. Seizure freedom was 88.8% (95% CI = 78.9%-94.3%) at 1-year follow-up and persisted at 85.5% (95% CI = 74.7%-92.0%) across 5- and 10-year follow-up in the vertical subgroup. In contrast, seizure freedom decreased from 89.2% (95% CI = 86.3%-91.5%) at 1-year to 72.1% (95% CI = 66.9%-76.7%) at 5-year to 57.2% (95% CI = 46.6%-66.4%) at 10-year follow-up for the lateral subgroup. Log-rank test found that vertical hemispherotomy was associated with durable seizure-free progression compared to the lateral approach (p = .01). Patients undergoing the lateral hemispherotomy technique had a shorter time-to-seizure recurrence (hazard ratio = 2.56, 95% CI = 1.08-6.04, p = .03) and increased seizure recurrence odds (odds ratio = 3.67, 95% CI = 1.05-12.86, p = .04) compared to those undergoing the vertical hemispherotomy technique. This pilot study demonstrated more durable seizure freedom of the vertical technique compared to lateral hemispherotomy techniques. Further studies, such as prospective expertise-based observational studies or a randomized clinical trial, are required to determine whether a vertical approach to hemispheric surgery provides superior long-term seizure outcomes.
Identifiants
pubmed: 34510448
doi: 10.1111/epi.17021
pmc: PMC9290517
doi:
Types de publication
Journal Article
Multicenter Study
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM
Pagination
2707-2718Subventions
Organisme : NICHD NIH HHS
ID : P50 HD105351
Pays : United States
Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2021 The Authors. Epilepsia published by Wiley Periodicals LLC on behalf of International League Against Epilepsy.
Références
Neurosurg Rev. 2018 Jan;41(1):125-132
pubmed: 28799142
J Neurosurg. 2004 Feb;100(2 Suppl Pediatrics):125-41
pubmed: 14758940
J Neurosurg Pediatr. 2013 Aug;12(2):126-33
pubmed: 23768201
Epilepsia. 2000 Apr;41(4):426-31
pubmed: 10756408
Epilepsy Behav. 2019 Apr;93:22-28
pubmed: 30780077
Neurosurgery. 2010 Dec;67(2 Suppl Operative):429-36
pubmed: 21099569
Epilepsia. 2009 Mar;50(3):510-20
pubmed: 18717706
Epilepsia. 2013 Nov;54(11):1905-12
pubmed: 24116936
J Neurosurg Pediatr. 2015 Jan;15(1):34-44
pubmed: 25380174
Can J Neurol Sci. 1983 May;10(2):71-8
pubmed: 6861011
J Neurosurg Pediatr. 2016 Dec;25(6):683-688
pubmed: 27611898
Acta Neurochir (Wien). 2012 Nov;154(11):2017-28
pubmed: 22941395
Epilepsia. 2021 May;62(5):1064-1073
pubmed: 33713438
World Neurosurg. 2021 Feb;146:e685-e690
pubmed: 33171323
Semin Pediatr Neurol. 2011 Sep;18(3):195-202
pubmed: 22062944
Epilepsia. 2012 Oct;53(10):1731-8
pubmed: 22958128
Neurology. 2013 Jan 15;80(3):253-60
pubmed: 23223541
Neurosurgery. 1995 Nov;37(5):975-81
pubmed: 8559348
Neurosurg Focus. 2020 Apr 1;48(4):E5
pubmed: 32234979
Neurology. 2005 Sep 27;65(6):912-8
pubmed: 16186534
Surg Neurol. 2009 Jun;71(6):631-7, discussion 637
pubmed: 18514273
Epilepsy Res. 2018 Jan;139:137-142
pubmed: 29247822
Neurosurgery. 1995 Mar;36(3):509-15; discussion 515-6
pubmed: 7753351
Epilepsia. 2018 Mar;59(3):e28-e33
pubmed: 29446447
Oper Neurosurg (Hagerstown). 2020 May 1;18(5):511-517
pubmed: 31407011
Neurosurgery. 2015 Apr;76(4):485-94; discussion 494-5
pubmed: 25710106
Neurosurgery. 2001 Oct;49(4):891-900; discussion 900-1
pubmed: 11564251
Pediatr Neurosurg. 2015;50(5):295-300
pubmed: 26277842
Epilepsia. 2013 Feb;54(2):383-9
pubmed: 23106378
J Neurosurg. 2019 Sep 20;:1-11
pubmed: 31597116
Neurosurgery. 2007 Feb;60(2 Suppl 1):ONS19-32; discussion ONS32
pubmed: 17297362
Electroencephalogr Clin Neurophysiol. 1995 Apr;94(4):265-70
pubmed: 7537198
J Neurosurg Pediatr. 2020 Jun 1;25(6):
pubmed: 33988937
J Neurosurg Pediatr. 2016 Nov;18(5):511-522
pubmed: 27472667
Childs Nerv Syst. 2006 Aug;22(8):967-81
pubmed: 16804712
Neurosurgery. 2014 Feb;74(2):182-94; discussion 195
pubmed: 24176954
BMJ. 2005 Jan 8;330(7482):88
pubmed: 15637373
J Neurosurg. 2007 Oct;107(4 Suppl):275-80
pubmed: 17941490
Cell. 1999 Jun 11;97(6):703-16
pubmed: 10380923
J Neurosurg Pediatr. 2015 Dec;16(6):681-6
pubmed: 26407094
Epilepsia. 2021 Nov;62(11):2707-2718
pubmed: 34510448
J Neurosurg. 2016 Apr;124(4):952-61
pubmed: 26495944